| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.00087 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00075 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |